The UK’s decision to scrap compulsory research unbundling, following the final recommendations of the Investment Research Review, marked one of the most striking developments for financial services firms in 2023. Permitting rebundling across the board with no market capitalisation threshold comes as part of a wider approach to reinvigorate UK capital markets. With the FCA expected to finalise its rule changes by midyear, firms accustomed to the MiFID II rules will need to adapt to the added flexibility regarding how they pay for investment research. In this episode of Connected with Latham, the latest in a 10-part series complementing Latham’s “10 Key Focus Areas for UK-Regulated Financial Services Firms in 2024” report, partner Rob Moulton talks with Giulia Pecce, Head of MiFID Policy, Research and Wholesale Investor Protection for the Association of Financial Markets in Europe (AFME), about the 2024 outlook for investment research. They discuss whether rule changes will likely be readily workable operationally, how quickly market practice might change, and the impact of EU reforms and US regulation on the UK’s ultimate approach to unbundling.
This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
Episode 79 – Pro Bono: Rewilding the Scottish Highlands Through Forest Restoration
Episode 78 – UK FinReg Focus Areas in 2024: ESG
Episode 77 – UK FinReg Focus Areas in 2024: Enforcement Against Individuals
Episode 76 – UK FinReg Focus Areas in 2024: Regulatory Divergence
Episode 75 – UK FinReg Focus Areas in 2024: Enforcement Against Firms
Episode 74 – UK FinReg Focus Areas in 2024: Conduct and Culture
Episode 73 – UK FinReg Focus Areas in 2024: Artificial Intelligence
Episode 72 – UK FinReg Focus Areas in 2024: The Edinburgh Reforms
Episode 71 – Drug Pricing: A Look Ahead at Trends for 2024
Episode 69 – UK FinReg Focus Areas in 2024: Retail Markets – Direction of Travel
Episode 68 – Drug Pricing: Will Agencies Exercise March-In Rights Based on Drug Price?
Episode 67 – PE Views: The Most Pressing Cybersecurity Considerations For Private Equity
Episode 66 – UK FinReg Focus Areas in 2024: Primary Markets Reform
Episode 65 – PE Views: How Can PE Sponsors Promote Transparency and Successful Fund Raise Amid ESG Scrutiny?
Episode 64 – Energy & Infrastructure: How Can Companies Avoid Greenwashing Allegations and ESG Litigation Risks?
Episode 63 – M&A Views: How Should Deal Teams Navigate a Global Crackdown on Restrictive Covenants?
Episode 62 – Has FDA Meaningfully Changed Its Restrictions on Off-Label Communications?
Episode 61 – Drug Pricing: New OIG Guidance Reaffirms the Seven Elements of an Effective Compliance Program
Episode 60 – PE Views: Is the CMA’s Focus on Roll-Up Transactions Here to Stay?
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
HCI Leadership Revolution
Human Capital Leadership
The Power of Music Thinking
BusinessWISE
Business Wars